Want to join the conversation?
Specialty pharmaceutical company $VRX said it announced new fulfillment agreements with $WBA and aims to extend this distribution model to additional participating independent retail pharmacies. Complementing the agreement, $VRX will reduce prices of its branded prescription-based dermatological and ophthalmological products by 10%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?